NORTHGATE SURGERY
NORTHGATE SURGERY, NORTHGATE, PONTEFRACT
CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 168 | 272 | 61.8% | |
| CKD 4 | 2008 | 196 | 247 | 79.4% | |
| CKD 5 | 2009 | 57 | 65 | 87.7% | |
| CKD 5 | 2010 | 11 | 12 | 91.7% | |
| CKD 5 | 2011 | 16 | 18 | 88.9% | |
| CKD 5 | 2012 | 15 | 15 | 100.0% | |
| CKD 5 | 2013 | 18 | 21 | 85.7% | |
| CKD003 | 2014 | 39 | 43 | 90.7% | |
| CKD003 | 2015 | 43 | 43 | 100.0% | |
| NM84 | 2016 | 52 | 64 | 81.2% | |
| NM84 | 2017 | 51 | 65 | 78.5% | |
| NM84 | 2018 | 49 | 62 | 79.0% | |
| NM84 | 2019 | 39 | 50 | 78.0% | |
| NM84 | 2020 | 37 | 50 | 74.0% | |
| NM84 | 2022 | 34 | 43 | 79.1% | |
| NM84 | 2023 | 43 | 52 | 82.7% |
